微生物宏基因组测序ORIGINGENE 文献标题：Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing 主要研究方法及结果：该研究使用20名健康个体的粪便样本，在BGISEQ-500平台上进行了包含8个文库重复和8个测序重复的设置，评估了其在宏基因组测序中的平台内重现性。通过比较BGISEQ-500平台与Illumin...
world. BGI’s goal is to make state-of-the-art genomics highly accessible to the global research community and clinical markets by integrating the industry’s broadest array of leading technologies, including BGI's own BGISEQ sequencing platform, economies of scale, and expert bioinformatics ...
BGI's Iso-Seq/PacBio transcriptome sequencing services are executed on PacBio's Sequel II platform. The Sequel II System has been recognized for its ability to generate longer reads with greater accuracy and throughput, at a significantly lower cost.Contact us with any general enquiries or qu...
BGI provides high quality, affordable sequencing services and NGS solutions for DNA Research & RNA research applications, multi-omics solutions and more.
System analysis of the sequencing quality of human whole exome samples on BGI NGS platformHuman exome sequencing is a classical method used in most medical genetic applications. The leaders in the field are the manufacturers of enrichment kits based on hybridization of cRNA or cDNA biotinylated ...
BGI Americas is a genomics solutions provider that specializes in sequencing services, bioinformatics, and multi-omics solutions.
BGI Cloud provides next-generation sequencing data storage and analyses to users who need to process large amounts of data while avoiding problems associated with data storage, delivery, and analysis. We help you set up a personalized bioinformatics platform on the cloud. With the high-performance...
and realized the closed-loop of upstream and downstream industrial chains of gene sequencing, laying a solid foundation for the long-term development of the biological industry. BGI's innovation and development has become a model for the development of modern enterprises. In 2013, BGI ranked second...
BGI in 2013 purchased Complete Genomics, a Nasdaq-listed human genome sequencing platform, for about $118 million after it raised Rmb1.4 billion by selling a 42% stake in BGI Tech to a consortium of private equity and venture capital investors one year earlier. Among them are China Everbright...
MGI Tech’s overall goal is to make the MGISEQ a versatile and open sequencing platform, said MGI CEO Mu Feng. MGI plans to release sequencing adapters and the test data to encourage users to develop their own applications on the MGISEQ platform. ...